(Q40651926)

22 September 2017

1 reference

title

Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations (English)

1 reference

22 September 2017

de Lalla F

1

1 reference

22 September 2017

1 May 1997

1 reference

22 September 2017

1 reference

22 September 2017

53

1 reference

22 September 2017

789-804

1 reference

22 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199753050-00005

22 September 2017

0 references

cites work

Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer

1 reference

12 December 2020

Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients

1 reference

12 December 2020

The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis

1 reference

12 December 2020

Ceftazidime Monotherapy for Empiric Treatment of Febrile Neutropenic Patients: A Metaanalysis

1 reference

12 December 2020

Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group

1 reference

12 December 2020

A meta-analysis of clinical studies of imipenem-cilastatin for empirically treating febrile neutropenic patients

1 reference

12 December 2020

Anti-infective strategies in neutropenia

1 reference

12 December 2020

Post-sepsis prophylaxis in cancer patients

1 reference

12 December 2020

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

12 December 2020

Monotherapy for empiric treatment of fever in granulocytopenic cancer patients

1 reference

12 December 2020

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Re

1 reference

12 December 2020

Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Canc

1 reference

12 December 2020

Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin

1 reference

12 December 2020

Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignancies

1 reference

12 December 2020

Guidelines for good practice in central venous catheterization. Hospital Infection Society and the Research Unit of the Royal College of Physicians

1 reference

12 December 2020

Infectious complications of indwelling vascular catheters

1 reference

12 December 2020

Ceftazidime as first-line therapy for fever in acute leukaemia

1 reference

12 December 2020

More extended-spectrum beta-lactamases

1 reference

12 December 2020

Management of fever in patients with central vein catheters

1 reference

12 December 2020

Hepatic candidiasis in cancer patients: the evolving picture of the syndrome

1 reference

12 December 2020

Value of semiquantitative cultures of blood drawn through catheter hubs for estimating the risk of catheter tip colonization in cancer patients

1 reference

12 December 2020

Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.

1 reference

12 December 2020

Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients

1 reference

12 December 2020

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines

1 reference

12 December 2020

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

1 reference

12 December 2020

Empiric treatment of infection during granulocytopenia: a comprehensive approach

1 reference

12 December 2020

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia

1 reference

12 December 2020

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

12 December 2020

Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients

1 reference

12 December 2020

Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant

1 reference

12 December 2020

Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes.

1 reference

12 December 2020

Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia

1 reference

12 December 2020

Empirical antibiotic therapy for fever in neutropenic patients

1 reference

12 December 2020

Relapsing Pseudomembranous Colitis Associated with Cancer Chemotherapy

1 reference

12 December 2020

Antibiotic therapy for gram-negative bacteremia

1 reference

12 December 2020

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer

1 reference

12 December 2020

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

12 December 2020

Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing Factors

1 reference

12 December 2020

Once-daily dosing of aminoglycosides

1 reference

12 December 2020

Problems in management of opportunistic fungal diseases

1 reference

12 December 2020

A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients

1 reference

12 December 2020

Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen

1 reference

12 December 2020

Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels

1 reference

12 December 2020

Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin

1 reference

12 December 2020

Fibronectin: a brief overview of its structure, function, and physiology

1 reference

12 December 2020

Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods

1 reference

12 December 2020

Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program

1 reference

12 December 2020

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

1 reference

12 December 2020

Outpatient management of febrile episodes in neutropenic cancer patients

1 reference

12 December 2020

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

1 reference

12 December 2020

Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of C

1 reference

12 December 2020

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer

1 reference

12 December 2020

Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients

1 reference

12 December 2020

Sepsis in febrile neutropenic children with cancer

1 reference

12 December 2020

Approach to treatment of the febrile cancer patient with low-risk neutropenia.

1 reference

12 December 2020

Principles of pharmacoeconomic analysis of drug therapy

1 reference

12 December 2020

Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

1 reference

12 December 2020

Challenging conventional aminoglycoside dosing regimens. The value of experimental models

1 reference

12 December 2020

Persistent fever after recovery from granulocytopenia in acute leukemia

1 reference

12 December 2020

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients

1 reference

12 December 2020

Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.

1 reference

12 December 2020

Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials

1 reference

12 December 2020

A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia

1 reference

12 December 2020

Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patients

1 reference

12 December 2020

Economic impact of oral ciprofloxacin. A pharmacist's perspective.

1 reference

12 December 2020

Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients.

1 reference

12 December 2020

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes

1 reference

12 December 2020

Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management

1 reference

12 December 2020

Empiric monotherapy in neutropenia: a realistic goal?

1 reference

12 December 2020

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

12 December 2020

Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients

1 reference

12 December 2020

Incidence and significance of Clostridium difficile in hospitalized cancer patients

1 reference

12 December 2020

Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients

1 reference

12 December 2020

Association of Respiratory Tract Colonization with Adherence of Gram-Negative Bacilli to Epithelial Cells

1 reference

12 December 2020

Granulocyte-macrophage colony stimulating factor (GM-CSF) as an adjunct to autologous bone marrow transplantation (ABMT) in hematology. Results of the interim analysis of the Schering-Plough/Sandoz International trial and considerations on increased

1 reference

12 December 2020

Antibiotics for the treatment of febrile children with neutropenia and cancer

1 reference

12 December 2020

Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model

1 reference

12 December 2020

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

1 reference

12 December 2020

Empiric Therapy with Amphotericin B in Febrile Granulocytopenic Patients

1 reference

12 December 2020

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

1 reference

12 December 2020

Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies

1 reference

12 December 2020

Empiric treatment of localized infections in the febrile neutropenic patient with monotherapy

1 reference

12 December 2020

Synergism at clinically attainable concentrations of aminoglycoside and beta-lactam antibiotics

1 reference

12 December 2020

Determinants of efficacy and toxicity of aminoglycosides

1 reference

12 December 2020

Therapy of infection in patients with granulocytopenia

1 reference

12 December 2020

Empirical antimicrobial therapy in the neutropenic host

1 reference

12 December 2020

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

1 reference

12 December 2020

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

12 December 2020

10.2165/00003495-199753050-00005

Identifiers

DOI

1 reference

PubMed ID

9129866

Dimensions Publication ID

22 September 2017

0 references

1 reference

PubMed ID

9129866